Hanna B. J.
- Country
- Poland
- Department
- Psychiatry
Research Overview
- A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DT-101 in Adults with Major Depressive Disorder
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Azetukalner in Patients with Bipolar Depression
- Efficacy and Safety of Zasocitinib in Pediatric Participants with Moderate-to-Severe Plaque Psoriasis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 302 of 589 partner sites.
Specializations
Psoriasis Management
The investigator specializes in treating moderate to severe plaque psoriasis, conducting extensive research into novel therapeutic approaches for both adult and pediatric populations.
- Systemic treatments for plaque psoriasis
- Pediatric psoriasis interventions
- Topical therapy development
Research focuses on evaluating long-term safety and efficacy of various therapeutic agents for psoriasis management.
Atopic Dermatitis Research
The investigator conducts comprehensive studies in moderate to severe atopic dermatitis, with particular emphasis on innovative treatment approaches across different age groups.
- Biologic therapy evaluation
- Pediatric dermatology treatments
- Combined therapy approaches
Studies include assessment of novel therapeutic agents in combination with topical corticosteroids.
Specialized Dermatological Conditions
The investigator's expertise extends to treating complex dermatological conditions, including alopecia areata and related autoimmune skin disorders.
- Advanced treatment protocols
- Long-term therapeutic outcomes
- Novel drug development
Research encompasses safety and efficacy evaluations of emerging treatments for various dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.